In cancer stem cells (CSCs) marked as CD44+/CD133+, restoring miR-34 reduced the CSC population by 87% by suppressing their growth and decreased tumor formation by lowering Bcl-2 and Notch1/2 levels. Here, BCL2 is linked to neoplasm.